|
Each 1ml
contains :
Composition:
Meropenem
......................................................................1
g
Meropenem
..................................................................500
mg
Indications :
Intra-abdominal infections, nosocominal pneumonia,
septicaemia, cystic fibrosis, meningitis, febrile
neutropenia.
Description:
The
bactericidal activity of meropenem results from the
inhibition of cell wall synthesis. Meropenem readily
penetrates the cell wall of most Gram-positive and
Gram-negative bacteria to reach penicillin-binding-
protein (PBP) targets. Its strongest affinities are
toward PBPs 2, 3 and 4 of Escherichia coli and
Pseudomonas aeruginosa; and PBPs 1, 2 and 4 of
Staphylococcus aureus.
Dosage :
Intra-abdominal infections; nosocominal pneumonia;
septicaemia: Adults: 500mg-1g hrly depending on the
severity and type. IV infusion, over approx. 15 to 30
minutes or as an intravenous bolus injection (5 to 20 mL)
over approximately 3-5minutes. Child: (3 months to 12
yrs): IV 10 to 40mg/kg 8hrly, or as reqd. Cystic
fibrosis; meningitis: Adults: 2g 8 hrly. Febrile
neutropenia: 1g 8 hrly.
Presentations:
Vial 1 ml
MRP
Retailer
Stockiest
1960.50 1568.40
1411.56 | 
